ロード中...

Once-monthly risedronate for postmenopausal osteoporosis

Bisphosphonates are the mainstay of treatment for postmenopausal women with osteoporosis. Despite numerous clinical trials documenting efficacy, tolerability, and safety of bisphosphonate therapy, long-term persistence and adherence to these agents remains low. This has serious consequences for pati...

詳細記述

保存先:
書誌詳細
主要な著者: Casadei, Kristina, Becker, Carolyn
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2971711/
https://ncbi.nlm.nih.gov/pubmed/21072270
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!